» Articles » PMID: 12902986

PSF-TFE3 Oncoprotein in Papillary Renal Cell Carcinoma Inactivates TFE3 and P53 Through Cytoplasmic Sequestration

Overview
Journal Oncogene
Date 2003 Aug 7
PMID 12902986
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Papillary renal cell carcinomas are associated with chromosomal translocations involving the helix-loop-helix leucine-zipper region of the TFE3 gene on the X chromosome. These translocations lead to the expression of TFE3 chimeras of PRCC, RCC17, NonO and PSF (PTB-associated splicing factor). In this study, we explored the role of PSF-TFE3 fusion protein in mediating cell transformation. Unlike wild-type TFE3 or PSF, which are nuclear proteins, PSF-TFE3 is not a nuclear protein and is targeted to the endosomal compartment. Although PSF-TFE3 has no effect on the nuclear localization of wild-type PSF, it sequesters wild-type TFE3 as well as p53 in the extranuclear compartment leading to functionally null p53 and TFE3 cells. In UOK-145 papillary renal carcinoma cells, which endogenously express PSF-TFE3, siRNA complementary to the PSF-TFE3 fusion junction leads to a reduction in PSF-TFE3 and redistribution of endogenous TFE3 and p53 from the cytoplasmic compartment to the nucleus. Our results indicate that PSF-TFE3 acts through a novel mechanism, and exports TFE3, p53 and possibly other factors from the nucleus to the cytoplasm for degradation leading to the transformed phenotype. Thus, PSF-TFE3 is a promising target for the treatment for a subset of renal cell carcinomas.

Citing Articles

Oncogenes and tumor suppressor genes: functions and roles in cancers.

Dakal T, Dhabhai B, Pant A, Moar K, Chaudhary K, Yadav V MedComm (2020). 2024; 5(6):e582.

PMID: 38827026 PMC: 11141506. DOI: 10.1002/mco2.582.


Established and Evolving Roles of the Multifunctional Non-POU Domain-Containing Octamer-Binding Protein (NonO) and Splicing Factor Proline- and Glutamine-Rich (SFPQ).

Yu D, Huang C, Tucker H J Dev Biol. 2024; 12(1).

PMID: 38248868 PMC: 10801543. DOI: 10.3390/jdb12010003.


Renal cell carcinoma associated with Xp11.2 translocation/transcription factor E3 gene fusion: A case report and literature review.

Yang D, Tang W, Liu M, Xie Z, Shi F, Zhao Z Oncol Lett. 2023; 27(1):29.

PMID: 38073770 PMC: 10698840. DOI: 10.3892/ol.2023.14162.


Xp11.2 translocation renal cell carcinoma with TFE3 gene fusion in the elderly: case report and literature review.

Masago T, Kobayakawa S, Ohtani Y, Taniguchi K, Naka T, Kuroda N Int Cancer Conf J. 2020; 9(4):182-186.

PMID: 32903928 PMC: 7450002. DOI: 10.1007/s13691-020-00430-6.


Molecular mechanisms and pathobiology of oncogenic fusion transcripts in epithelial tumors.

Tuna M, Amos C, Mills G Oncotarget. 2019; 10(21):2095-2111.

PMID: 31007851 PMC: 6459343. DOI: 10.18632/oncotarget.26777.